Medline Ophthalmic Pack W/Lido Recall Issued
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries is recalling 180 Ophthalmic Pack W/Lido kits due to quality issues with contained lidocaine ampules.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 8, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, medical-devices.
What Happened
Medline Industries, LP initiated a voluntary recall of certain convenience kits containing Huons Lidocaine HCL Injection USP 1% 10mg/ml 5mL Ampules. The action follows a recall notice from Huons Co., Ltd. citing quality issues identified during an FDA manufacturing inspection.
Which Products Are Affected
- Product: Medline Convenience Kits - OPHTHALMIC PACK W/LIDO
- Model Number: DYNJ57922A
- Lot Number: 25JLA852
- UDI-DI: 10195327556259 (each), 40195327556250 (case)
- Quantity: 180 kits
- Distribution: US Nationwide
- Recall Number: Z-2547-2026
- Classification: Class II
What You Should Do
Consumers in possession of the affected kits should verify the model and lot number and contact Medline Industries, LP for further instructions.
Why This Matters
This Class II recall addresses potential quality concerns with the lidocaine component in kits distributed nationwide.
Source
FDA recall Z-2547-2026, initiated May 21, 2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (966 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 8, 2026.
Frequently Asked Questions
Common questions about this FDA recall.